- Report
- February 2026
- 250 Pages
Global
From €4146EUR$4,490USD£3,502GBP
- Report
- September 2026
- 187 Pages
Global
From €3273EUR$3,545USD£2,765GBP
€3637EUR$3,939USD£3,072GBP
- Report
- January 2026
- 189 Pages
Global
From €3273EUR$3,545USD£2,765GBP
€3637EUR$3,939USD£3,072GBP
- Report
- July 2026
- 250 Pages
Global
From €4146EUR$4,490USD£3,502GBP
- Report
- February 2026
- 250 Pages
Global
From €4146EUR$4,490USD£3,502GBP
- Report
- October 2026
- 588 Pages
Global
From €5401EUR$5,850USD£4,563GBP
- Report
- October 2026
- 378 Pages
Global
From €5401EUR$5,850USD£4,563GBP
- Report
- June 2026
- 180 Pages
Global
From €4386EUR$4,750USD£3,705GBP
- Report
- July 2026
- 150 Pages
Global
From €3462EUR$3,750USD£2,925GBP
- Report
- August 2026
- 171 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- August 2026
- 178 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- July 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- October 2025
- 160 Pages
Global
From €2918EUR$3,160USD£2,465GBP
€3647EUR$3,950USD£3,081GBP
- Report
- June 2026
- 52 Pages
Global
From €6925EUR$7,500USD£5,849GBP
- Report
- July 2026
- 90 Pages
United States
From €4386EUR$4,750USD£3,705GBP
- Report
- May 2026
- 131 Pages
Europe
From €5535EUR$5,995USD£4,676GBP
- Report
- May 2026
- 124 Pages
North America
From €5535EUR$5,995USD£4,676GBP
- Report
- May 2026
- 124 Pages
Asia Pacific
From €5535EUR$5,995USD£4,676GBP
- Report
- August 2023
- 146 Pages
Global
From €1745EUR$1,890USD£1,474GBP
- Report
- October 2023
- 305 Pages
Global
From €3878EUR$4,200USD£3,276GBP

The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more